The Premier Sugar Mills & Distillery Company Limited (PSX:PMRS)

Verve Therapeutics Revenue

The Premier Sugar Mills & Distillery Company had revenue of 7.38B PKR in the quarter ending June 30, 2025, a decrease of -34.80%. This brings the company's revenue in the last twelve months to 34.94B, down -1.51% year-over-year. In the fiscal year ending September 30, 2024, The Premier Sugar Mills & Distillery Company had annual revenue of 39.40B with 37.52% growth.

• Revenue (ttm): 34.94B
• Revenue Growth: -1.51%
• P/S Ratio: 0.03
• Revenue / Employee: 24.94M
• Employees: 1,401
• Market Cap: 1.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	39.40B	10.75B	37.52%
Sep 30, 2023	28.65B	10.94B	61.76%
Sep 30, 2022	17.71B	1.20B	7.30%
Sep 30, 2021	16.51B	50.19M	0.31%
Sep 30, 2020	16.46B	2.98B	22.16%